Diao Chen

Diao Chen is a seasoned professional with extensive experience in medicinal chemistry and chemical biology. They earned a Doctor of Philosophy in Organic Chemistry from the University of Chinese Academy of Sciences, completing significant research on asymmetric synthesis. Diao's recent roles include serving as the Sr. Director of Chemistry at Eli Lilly and Company, following their position as Director of Insulin Engineering at Protomer Technologies, where they specialized in glucose-responsive insulin development. They have contributed to groundbreaking work in diabetes and metabolic research through their various academic and professional roles.